China National Accord Medicines Co. Ltd.

Pharmaceuticals
China
Executive 1Yan Zhigang, General Manager; | General Manager;
Executive 2Lin Zhaoxiong, Deputy General Manager; | Vice-Chairman;
Earnings Per Share Growth (%)4.97%
Cost of Goods Sold (US$ Millions)$3,545
Current Liabilities (US$ Millions)$1,239
Total Assets (US$ Millions)$1,771
Long Term Debt (Millions)$6
Return on Equity29.84%
Revenue (US$ Millions)$3,868
Total Company Assets$2,067
Revenue Growth (%)13.01%
Net Income (US$ Millions)$108
Earnings Per Share (US$)$0.31
Total Equity (US$ Millions)$768
Profit Margin (%)2.79%
Debt To Equity Ratio (%)0.01%
Inventories (Millions)$374